Genmab
GMAB
#1266
Rank
NZ$24.56 B
Marketcap
$38.68
Share price
-0.13%
Change (1 day)
-26.89%
Change (1 year)

Market capitalization of Genmab (GMAB)

Market cap: NZ$24.56 Billion

As of November 2024 Genmab has a market cap of NZ$24.56 Billion. This makes Genmab the world's 1266th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Genmab from 2010 to 2024

End of year Market Cap

Year Marketcap Change
2024NZ$24.56 B-25.29%
2023NZ$32.88 B-25.3%
2022NZ$44.02 B14.85%
2021NZ$38.33 B3.67%
2020NZ$36.98 B72.75%
2019NZ$21.40 B43.2%
2018NZ$14.94 B5.32%
2017NZ$14.19 B-2.01%
2016NZ$14.48 B23.91%
2015NZ$11.68 B173.31%
2014NZ$4.27 B73.07%
2013NZ$2.47 B193.06%
2012NZ$0.84 B124.09%
2011NZ$0.37 B-52.11%
2010NZ$0.78 B

End of Day market cap according to different sources

On Nov 9th, 2024 the market cap of Genmab was reported to be:

NZ$24.56 Billion
by Yahoo Finance info icon info icon
NZ$24.56 Billion
by CompaniesMarketCap info icon info icon
NZ$25.56 Billion
by Nasdaq info icon info icon